Clinical Trials Directory

Trials / Conditions / Acinetobacter Baumannii Infection

Acinetobacter Baumannii Infection

6 registered clinical trials studyying Acinetobacter Baumannii Infection — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingComparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resis
NCT07118384
Cairo UniversityN/A
Active Not RecruitingCefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex I
NCT07226557
National Institutes of Health Clinical Center (CC)—
CompletedEvaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered
NCT03310463
Entasis TherapeuticsPhase 1
CompletedEvaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Sub
NCT02971423
Entasis TherapeuticsPhase 1
CompletedEffects of Immune Function on Prognositic Outcome in Critical Ill Patients With Acinetobacter Baumannii Infect
NCT02886637
Southeast University, China—
No Longer AvailablePersonalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bac
NCT04636554
Adaptive Phage Therapeutics, Inc.—